The only sure thing about the Trump administration is that nothing is a sure thing.
When Scott Gottlieb left the Food and Drug Administration last spring, it appeared that his interim replacement, Ned Sharpless, would likely succeed him as commissioner on a permanent basis.
After all, Sharpless checks a lot of boxes – physician, scientist, academic, biotech co-founder. He’s also headed the National Cancer Institute. Moreover, he was recommended by the politically astute Gottlieb, who won praise from President Trump as a “star,” suggesting his pick might be favored.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect